iBio
IBIO
#9327
Rank
HK$0.65 B
Marketcap
HK$19.01
Share price
2.10%
Change (1 day)
-57.22%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: HK$0.65 Billion

As of March 2026 iBio has a market cap of HK$0.65 Billion. This makes iBio the world's 9327th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.65 B98.62%
2025HK$0.33 B90.02%
2024HK$0.17 B711.19%
2023HK$21.45 M-31.37%
2022HK$31.25 M-96.65%
2021HK$0.93 B-45.87%
2020HK$1.72 B1528.96%
2019HK$0.10 B-4.78%
2018HK$0.11 B-30.35%
2017HK$0.15 B-41.54%
2016HK$0.27 B-18.67%
2015HK$0.33 B-12.24%
2014HK$0.38 B128.46%
2013HK$0.16 B-27.08%
2012HK$0.22 B9.97%
2011HK$0.20 B-73.71%
2010HK$0.79 B302.5%
2009HK$0.19 B936.59%
2008HK$19.03 M

End of Day market cap according to different sources

On Mar 11th, 2026 the market cap of iBio was reported to be:

HK$0.64 Billion
by Nasdaq info icon info icon
HK$0.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.581 T 697,511.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
HK$0.04 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$16.05 B 2,344.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$3.36 B 411.80%๐Ÿ‡บ๐Ÿ‡ธ USA